In a seismic ruling Monday, the UK High Court upheld the British government’s ban on puberty blockers, citing a study that found “very substantial risks and very narrow benefits” of early puberty suppression.
Read More
Over at Compact magazine on Tuesday, Nina Power wrote “The Trans Reckoning Is Here,” and, as evidence, she cited a report by a British pediatrician named Hilary Cass written for the National Health Service that upturned the faux-scientific basis on which that country has embarked on normalizing “gender-affirming care.”
Read More
There is “weak evidence” to support puberty blockers for children who identify as transgender, according to a four-year systematic review of transgender medical studies published on Tuesday.
Dr. Hilary Cass, a consultant in paediatric disability at St. Thomas’ Hospital in London, England, and formerly the president of the Royal College of Pediatrics and Child Health, conducted the review in response to a request from the National Health Service (NHS). Cass’ report determined that the current studies on the subject of “puberty suppression” showed little improvement in gender dysphoria in minors and also may push kids toward getting more extreme treatments.
Read More
England’s National Health Service (NHS) has banned the use of puberty blockers to treat children with gender dysphoria at the nation’s gender identity clinics, Sky News reported.
Taking a position at odds with the Biden administration, Health Minister Maria Caulfield said: “We have always been clear that children’s safety and wellbeing is paramount, so we welcome this landmark decision by the NHS. Ending the routine prescription of puberty blockers will help ensure that care is based on evidence, expert clinical opinion and is in the best interests of the child.”
Read More